Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

How I treat cold agglutinin disease

Sigbjørn Berentsen

Blood (2021) 137 (10): 1295–1303.

https://doi.org/10.1182/blood.2019003809

Published: 2021

Journal Articles

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Alexander Röth, Wilma Barcellini, Shirley D'Sa, Yoshitaka Miyakawa, Catherine M Broome, Marc Michel, David J. Kuter, Bernd Jilma, Tor Henrik Anderson Tvedt, Stella Lin, Xiaoyu Jiang, Caroline Reuter, William Hobbs, Sigbjørn Berentsen

Blood (2019) 134 (Supplement_2): LBA-2.

https://doi.org/10.1182/blood-2019-132490

Published: 2019

Journal Articles

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial

Ulrich Jäger, Shirley D’Sa, Christian Schörgenhofer, Johann Bartko, Ulla Derhaschnig, Christian Sillaber, Petra Jilma-Stohlawetz, Michael Fillitz, Thomas Schenk, Gary Patou, Sandip Panicker, Graham C. Parry, James C. Gilbert, Bernd Jilma

Blood (2019) 133 (9): 893–901.

https://doi.org/10.1182/blood-2018-06-856930

Published: 2019

Includes: Supplemental data

Journal Articles

Complement Inhibition with C1 Esterase Inhibitor Allowed Successful Transfusion of HLA Mismatched Platelets in a Transfusion Refractory Alloimmunized Patient: A Case Report

Maryam Sarraf Yazdy, MD, Catherine Broome, MD

Blood (2017) 130 (Supplement 1): 4845.

https://doi.org/10.1182/blood.V130.Suppl_1.4845.4845

Published: 2017

Journal Articles

Supra-Physiological Concentrations of C1 Esterase Inhibitor Enhance Thrombin Generation in the Presence of Thrombomodulin

Ivan Tarandovskiy, PhD, Paul Buehler, Ph. D., Elena Karnaukhova

Blood (2017) 130 (Supplement 1): 2353.

https://doi.org/10.1182/blood.V130.Suppl_1.2353.2353

Published: 2017

Journal Articles

Chronic Inhibition of Complement C1s By TNT009 Produces Sustained, Complete Remission in Patients with Severe, Transfusion-Dependent Cold Agglutinin Disease (CAD)

Bernd Jilma, MD, James C Gilbert, MD, Sandip Panicker, PhD, Graham C Parry, PhD, Michael Fillitz, MD, Schenk Thomas, Christian Sillaber, MD, Johann Bartko, MD, Ulrich Jaeger, MD

Blood (2016) 128 (22): 2435.

https://doi.org/10.1182/blood.V128.22.2435.2435

Published: 2016

Journal Articles

Complement Blockade with C1 Esterase Inhibitor in Severe C3d Positive Autoimmune Hemolytic Anemia

Jasmin Desai, MD, Catherine Broome, MD

Blood (2016) 128 (22): 4817.

https://doi.org/10.1182/blood.V128.22.4817.4817

Published: 2016

Journal Articles

Complement Blockade with C1 Esterase Inhibitor in Refractory Immune Thrombocytopenia

Erin Elizabeth Roesch, MD, Catherine Broome, MD

Blood (2015) 126 (23): 2253.

https://doi.org/10.1182/blood.V126.23.2253.2253

Published: 2015

Journal Articles

C1-esterase inhibitor concentrate rescues erythrocytes from complement-mediated destruction in autoimmune hemolytic anemia

Diana Wouters, Femke Stephan, Paul Strengers, Masja de Haas, Conny Brouwer, Anton Hagenbeek, Marinus H. J. van Oers, Sacha Zeerleder

Blood (2013) 121 (7): 1242–1244.

https://doi.org/10.1182/blood-2012-11-467209

Published: 2013

Journal Articles

Protease Generation by Chondroitin Sulfate, Semisynthetic OSCS Preparations and Contaminants Isolated From Heparin.

Melanie Clark, Nasir Sadeghi, Debra Hoppensteadt, Lauren Myers, Vinod Bansal, Eduardo Ramacciotti, M.D., Ph.D., Jawed Fareed

Blood (2009) 114 (22): 3133.

https://doi.org/10.1182/blood.V114.22.3133.3133

Published: 2009

Journal Articles

Pharmacokinetics, Clinical Efficacy and Safety of Plasma-Derived Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary and Acquired Angioedema.

J. J. Hofstra, MD, E. van Twuyver, PhD, I. Kleine-Budde, PhD, C. W. Choi, MD, PhD, M. Levi, MD, PhD, F. W.G. Leebeek, MD, PhD, J. G.R. de Monchy, MD, PhD, P. F. Ypma, MD, PhD, A. D. Huitema, PhD, A. Nienhuis, P. F. Strengers, PhD

Blood (2008) 112 (11): 1988.

https://doi.org/10.1182/blood.V112.11.1988.1988

Published: 2008

Journal Articles

Two Virus Reduction Steps Are Inherent in the Manufacturing Process of Berinert P, a C1-Esterase-Inhibitor Concentrate.

Albrecht Groener, Thomas Nowak, Wolfram Schäfer

Blood (2005) 106 (11): 4170.

https://doi.org/10.1182/blood.V106.11.4170.4170

Published: 2005

NARROW

How I treat cold agglutinin disease

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial

Complement Inhibition with C1 Esterase Inhibitor Allowed Successful Transfusion of HLA Mismatched Platelets in a Transfusion Refractory Alloimmunized Patient: A Case Report

Supra-Physiological Concentrations of C1 Esterase Inhibitor Enhance Thrombin Generation in the Presence of Thrombomodulin

Chronic Inhibition of Complement C1s By TNT009 Produces Sustained, Complete Remission in Patients with Severe, Transfusion-Dependent Cold Agglutinin Disease (CAD)

Complement Blockade with C1 Esterase Inhibitor in Severe C3d Positive Autoimmune Hemolytic Anemia

Complement Blockade with C1 Esterase Inhibitor in Refractory Immune Thrombocytopenia

C1-esterase inhibitor concentrate rescues erythrocytes from complement-mediated destruction in autoimmune hemolytic anemia

Protease Generation by Chondroitin Sulfate, Semisynthetic OSCS Preparations and Contaminants Isolated From Heparin.

Pharmacokinetics, Clinical Efficacy and Safety of Plasma-Derived Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary and Acquired Angioedema.

Two Virus Reduction Steps Are Inherent in the Manufacturing Process of Berinert P, a C1-Esterase-Inhibitor Concentrate.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only